Insulin enters the blood circulation and acts on the various organs and tissues to regulate glucose metabolism. Insulin binds to its specific cell surface receptors, activates a complex signal transduction pathway, and eventually leads to the opening of cell surface channels that take up glucose from the blood stream. The end result is the lowering of the blood glucose level.

Any blockade or efficiency decrease in this signaling pathway will result in compromised insulin action, affecting insulin’s ability to regulate blood glucose. This is called insulin resistance. To compensate the decreased insulin sensitivity, human body produces more and more insulin. This leads to hyper-insulinia. The sustained high insulin level in the blood have detrimental effects on other metabolic processes, such as lipid metabolism and sex hormone metabolism. The broad category of human diseases resulting from insulin resistance is called X Syndrome and includes diabetes, high blood pressure, obesity, stroke, PCOS, etc.

Researches carried out in the last two decades at various laboratories have indicated that inositol molecules, particularly D-chiro-inositol and Myo-inositol, are important mediators for insulin action. D-chiro-inositol was found to be present in the urine and blood of normal people but absent or at much reduced level in those of Type 2 diabetic patients, suggesting that Type 2 diabetic patients may not produce enough Inositol A and therefore exhibit a decrease in insulin sensitivity.

Quality Specification

Total Chiro-Inositol ≥1700mg/100g

(D-chiro-inositol and Myo-inositol)

Total Flavones(Rutin as Standard) ≥460mg/100g

Physiological Functions

• Reduces Serum Glucose in Streptozotocin-Diabetic Rats and in Type 2 diabetes patients have been tested

• Dominant effect on hyperlipidemia rats have been tested.

• Reported good effect on PCOS, hypertension, obesity(we plan to test it)

Safety

Superior safety profile with no side effect tested by animal experiments

【Suggested Use】: Take 3 capsule orally with warm water,

【Specification】: 280mg per capsule, 90 capsules per bottle

【Approval No.】: QianWeiShiZhunZi（2002）No.061

【Storage】: Put in cool, dry place.

【Shelf Life】: 2 years.

Manufacturer: Zunyi Bosi Bioengineering Co., Ltd.

Address: No. 72, Zhonghua Rd., Zunyi, city Guizhou province, China

Web: www.bosicompany.com

E-mail: bosicompanhy@163.com  

Ingredient List of Bosi Sugar Reducing Capsule

Specification: 280mg per capsule.
Shelf life:    24 months
All methods employed in the manufacture of the above-mentioned product are in strict accordance with the Regulations Of Food and Health Laws of the People’s Republic of China. No ingredients except the above-mentioned are used at all in this formula. The expiration date is for 2 years after production.